Public access to research data offers clear benefits for reproducibility in some fields. But in the world of cancer cell biology, complexity reigns, and replicating results is not so easy a process.
The story of a teenage science whiz who used free information sources to create a novel cancer screening test may be full of holes. Whether it is or not, it no longer seems the clear, happy story the media wanted to tell.
When brands, credibility, and trust all stumble, what is an increasingly weary public supposed to think?